349 related articles for article (PubMed ID: 16304886)
41. Severe community-acquired pneumonia: an Australian perspective.
Wilson PA; Ferguson J
Intern Med J; 2005 Dec; 35(12):699-705. PubMed ID: 16313544
[TBL] [Abstract][Full Text] [Related]
42. [Guideline 'Diagnosis and treatment of community-acquired pneumonia' from the Dutch Thoracic Society].
van Zanten AR; Tjan DH; van Leeuwen HJ
Ned Tijdschr Geneeskd; 2006 Mar; 150(9):518-9; author reply 519-20. PubMed ID: 16553054
[No Abstract] [Full Text] [Related]
43. Usefulness of aetiological tests for guiding antibiotic therapy in community-acquired pneumonia.
Strålin K
Int J Antimicrob Agents; 2008 Jan; 31(1):3-11. PubMed ID: 17920819
[TBL] [Abstract][Full Text] [Related]
44. [Optimizing the antibiotics policy in the Netherlands. IV. SWAB- guidelines for antimicrobial therapy of adults with sepsis in hospitals. Foundation Antibiotics Policy Work Group].
van Kasteren ME; Stobberingh EE; Janknegt R; Wijnands WJ; van der Meer JW
Ned Tijdschr Geneeskd; 1999 Mar; 143(12):611-7. PubMed ID: 10321287
[TBL] [Abstract][Full Text] [Related]
45. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
Charles PG; Whitby M; Fuller AJ; Stirling R; Wright AA; Korman TM; Holmes PW; Christiansen KJ; Waterer GW; Pierce RJ; Mayall BC; Armstrong JG; Catton MG; Nimmo GR; Johnson B; Hooy M; Grayson ML;
Clin Infect Dis; 2008 May; 46(10):1513-21. PubMed ID: 18419484
[TBL] [Abstract][Full Text] [Related]
46. Pharmacotherapy of childhood pneumonia.
Nascimento-Carvalho CM
Expert Opin Pharmacother; 2010 Feb; 11(2):225-31. PubMed ID: 20088744
[TBL] [Abstract][Full Text] [Related]
47. Clinical experience in the management of community-acquired pneumonia: lessons from the use of fluoroquinolones.
Carratalá J; Martín-Herrero JE; Mykietiuk A; García-Rey C
Clin Microbiol Infect; 2006 May; 12 Suppl 3():2-11. PubMed ID: 16669924
[TBL] [Abstract][Full Text] [Related]
48. The Centers for Medicare and Medicaid Services (CMS) community-acquired pneumonia core measures lead to unnecessary antibiotic administration by emergency physicians.
Nicks BA; Manthey DE; Fitch MT
Acad Emerg Med; 2009 Feb; 16(2):184-7. PubMed ID: 19133854
[TBL] [Abstract][Full Text] [Related]
49. [Questionnaire survey of guideline implementation for community acquired pneumonia with retrospective analysis of the empiric treatment in 490 patients].
Xu ZJ; Ding K; Huang H; Sun TY; Ke HX; Tong ZH; Wei TN; Peng K; Yao B; Li FX; Liu JH; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):442-6. PubMed ID: 17673019
[TBL] [Abstract][Full Text] [Related]
50. [Community-acquired pneumonia--treatment perspectives in the physician's office].
Ewig S
MMW Fortschr Med; 2004 May; 146(21):43-5. PubMed ID: 15373084
[TBL] [Abstract][Full Text] [Related]
51. [Optimizing antibiotics use policy in the Netherlands. I. The Netherlands Antibiotics Policy Foundation (SWAB)].
van Kasteren ME; Wijnands WJ; Stobberingh EE; Janknegt R; Verbrugh HA; van der Meer JW
Ned Tijdschr Geneeskd; 1998 Apr; 142(17):949-51. PubMed ID: 9623167
[TBL] [Abstract][Full Text] [Related]
52. [Management of adult patients with community-acquired pneumonia. Evidence-based guidelines from the Swedish Infectious Diseases Association].
Strålin K; Goscinski G; Hedlund J; Lidman C; Spindler C; Ortqvist A; Holmberg H
Lakartidningen; 2008 Sep 17-23; 105(38):2582-7. PubMed ID: 18846863
[No Abstract] [Full Text] [Related]
53. The alphabet soup of pneumonia: CAP, HAP, HCAP, NHAP, and VAP.
Anand N; Kollef MH
Semin Respir Crit Care Med; 2009 Feb; 30(1):3-9. PubMed ID: 19199181
[TBL] [Abstract][Full Text] [Related]
54. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.
Micek ST; Kollef KE; Reichley RM; Roubinian N; Kollef MH
Antimicrob Agents Chemother; 2007 Oct; 51(10):3568-73. PubMed ID: 17682100
[TBL] [Abstract][Full Text] [Related]
55. Managing CAP: an evidence-based algorithm.
Bernheisel CR; Schlaudecker JD
J Fam Pract; 2007 Sep; 56(9):722-6. PubMed ID: 17764643
[TBL] [Abstract][Full Text] [Related]
56. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia.
Charles PG; Wolfe R; Whitby M; Fine MJ; Fuller AJ; Stirling R; Wright AA; Ramirez JA; Christiansen KJ; Waterer GW; Pierce RJ; Armstrong JG; Korman TM; Holmes P; Obrosky DS; Peyrani P; Johnson B; Hooy M; ; Grayson ML
Clin Infect Dis; 2008 Aug; 47(3):375-84. PubMed ID: 18558884
[TBL] [Abstract][Full Text] [Related]
57. Guideline adherence for empirical treatment of pneumonia and patient outcome. Treating pneumonia in the Netherlands.
Huijts SM; van Werkhoven CH; Boersma WG; Buijs J; Buunk G; Compaijen CJ; van Elde LJ; Gisolf JE; van der Kam R; Kluytmans JA; Kuipers BA; Mager JJ; Oppedijk B; Palmen F; Prins JM; van Reemst B; Silbermann MH; van Tiel FH; van der Wall E; van der Werf TS; Bonten MJ
Neth J Med; 2013 Dec; 71(10):502-7. PubMed ID: 24394734
[TBL] [Abstract][Full Text] [Related]
58. [Anglo-Saxon guidelines for the treatment of community-acquired pneumonia also applicable in The Netherlands].
Koolbergen K
Ned Tijdschr Geneeskd; 1997 Nov; 141(45):2201; author reply 2201-2. PubMed ID: 9644005
[No Abstract] [Full Text] [Related]
59. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results.
Arnold FW; LaJoie AS; Brock GN; Peyrani P; Rello J; Menéndez R; Lopardo G; Torres A; Rossi P; Ramirez JA;
Arch Intern Med; 2009 Sep; 169(16):1515-24. PubMed ID: 19752410
[TBL] [Abstract][Full Text] [Related]
60. Identifying barriers to the rapid administration of appropriate antibiotics in community-acquired pneumonia.
Barlow G; Nathwani D; Myers E; Sullivan F; Stevens N; Duffy R; Davey P
J Antimicrob Chemother; 2008 Feb; 61(2):442-51. PubMed ID: 18065412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
